Aids in Infants and Children
Abstract
Children are infected by HIV, 80% vertically, from HIV infected mothetS mostly near or at delivery. Because heterosexual transmission of HIV among adults is more and more important it is estimated that at the end of this century there will be totally more than 10 million HIV infected children.
Three quarters of HIV-infected babies show non specific symptoms at the early phase, including failure to thrive, chronic diarrhea, recurrent bacterial injections, mucocutanous infection.
Cytotropism of HIV to neroe cells resul.ts tn inflammation, neroe cell damage and neuronal loss. Progressive neurologic abnormalities and developmental milestone regression or developmental retardation will be the results. Pneumocystics carinii infection has worse prognosis than lymphocytic interstitial pneumonia which more commonly occurred in HIV injected children. Diarrhea is a troublesome problem in children with AIDS. Kaposi's sarcoma and secondary cancer are rare in pediatric AIDS. Anemia and thrombocytopenia is common among AIDS children. In developing countries children with AIDS die within the year following the appearance of the symptoms, whereas asymptomatic HIV-injected children will live longer with high risk of recurrent and opportunistic injections.
The hallmark of AIDS in children is the same as in adults,iI.e. the decrease of the number and function of CD4 lymphocytes. This in turn influences the junctions of other immunocompetent cells and loss of immunity is the result. Many things are still unexplainable in children AIDS.
References
2. Nunn P and McAadam KPWJ. AIDS in Africa. Medicine International 1988; 3 : 2357- 60.
3. WHOb. World AIDS Day, HN : A dangerously divisve virus, 1991. Geneva
4. WHOa. WHO Press, 1991. Geneva
5. Tappin DM, Girdwood RWA, Folliet EAC, Kennedy R, Brown AJ, Cockburn F, Prevalence of maternal HN infection in Scotland based on unliked anonymous testing newborn babies. Lancet 1991; 337 : 1565 - 7.
6. Ades AE, ParkerS, Berry T, Holland Fj, eta!. Prevalence on maternal HN-1 infection in Thames Regions : results from anonymous unliked neonatal testing. Lancet 1991; 337: 1562-4.
7.- Ehmst A, Lindgren S, Dictor M, et.al. HIV in pregnant women and their offspring : evidence for late transmission, Lancet 1991; 338: 203-6.
8. Goedert Jj, Duliege AM, amos CJ, Felton S, Biggar RJ. High risk of HN-1 infection for firstborn twins. Lancet 1991; 338 : 1471- 4.
9. Mok JYQ. HN infection in infants and children. Medicine lnternational1991; 3 : 2360:3.
10. Jones DS, Byers RH, Bush 1}, Oxtobby MJ, Rogers MF. Epidemiology of transfusion-associated
acquired immunodeficiency syndrome in children in the united states, 1981 through 1989 - 199L Pediatrics 1991; 89 : 123 - 7.
11. WHO. Global programme on AIDS – internal conference on the implications of AIDS for the mothers and children : Technical Statements and selected presentations, Paris 27 – 30 Nov. 1989
12. Steihm ER, Vink P. Transmission of human immunodeficiency virus infection by breast feeding. J Pediatr 1991; 118 : 410 2,
13. Hers BS, Provici F, Apetrei RC, et al. Acquired immunodeficiency syndrome in Romania, Lancet 1991; 338: 645 9.
14. European Collaborative study. Children born to women with HN-1 infection natural history and risk of transmission. Lancet 1991; 337 : 253 - 9.
15. Alder MW. AIDS- an introduction. Medicine International1988; 3 : 2326- 9.
16. Cohen SE, Mundy T, Kararrik B, Lieb, Ludwing DD, Ward J. Neuropsychological functioning in human immunodeflency virus type 1 serospositive children infected through neonatal blood transfusion. Pediatrics. 1991; 88: 58- 68.
17. Yolken RH, Hart W, Oung I, Shieff C, Greenson J, Perman JA. Gastrointestinal dysfunction and disaccharide intolerance in children infected with human immunodeficiency virus. J Pediatr 1991; 118 : 359- 63.
18. Mortimer PP. The AIDS virus and the HN test Medicine lnternational1988; 3 : 2334 - 9,
19. MMWR. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. JAMA SEA 1990; 6 : 7 - 9.
20. Mortimer PP. The fallibility of HN Western blot. Lancet 1991; 337: 286- 7.
21. Martin NL, Levy JA, Legg H, Weintrub PS, Cow an MJ, Wara DW. Detection of Infection with human irrununodeficiency virus (HlV) type 1 in infants by an anti-HlV irrununoglobulin A assay using recombinant. J Pediatr 1991; 118 : 354- 8.
22. Levy JA. Human irrununodeficiency virus the pathogenesis of AIDS.JAMA SEA 1989; 5 : 35-46.
23. Srugo I, Brunell PA, Chelyapov NV, Ho DD, Masud Alam MS, Israele V. Virus burden in human immunodeficiency virus type 1-infected children : Relationship to disease status and effect of antiviral
therapy. Pediatrics 1991; 87 : 921 - 5.
24. Alimneti A, Luzuriaga K, Stechenberg B, Sullivan JL. Quantitation of human immunodeficiancy virus in vertically infected Wants and children. J Pediatr 1991; 119 : 225- 9.
25. Sirrunonds P, Beatson D, Cuthbert RJ G et al. Determinants of HIV disease progression : six year longitudinal study in the Edinburgh haemophilia/HIV cohort. Uincet 1991; 338 : 1159-63.
26. Brenner TJ, Dahl KE, Olson B, Miller G, Andiman W A. Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children. Lancet 1991; 337 : 1001 - 5.
27. Luzuriage K, Koup RA, Pikora CA, Brettler DB, sullivan JL. Deficient human irrununodeficiency virus type 1 specific cytotoxic T cell responses in vertically infected children. J Pediatr 1991; 119 : 230- 6.
28. Roilides E, Clerici M, DePalma L, Rubin M, Pizzo PA, Shearer GM. Helper T-cell responses in children infected with human irrununodeficiency virus type 1. J Pediatr 1991; 118 : 724-30.
29. Phillips AN, I.e CA, Elford], Janossy G, Timms A, Bofill M, Kemoff PBA. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337 : 389 - 92.
30. Rapheal AS, Price ML, Lischner HW, Griffm JW, Grover WD, Bagasra 0. lnflammatory demyelinating polyneuropathy in a child with symptomatic human immunodeficiency virus infection J Pediatr 1991; 118 : 242 - 5.
31. Everall IP, Luthert PJ, Uintos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337:1119-21
32. Keating]N, Trimble KC, MulcahyF, ScottJM, Weir DG. Evidence of brain methyltransferase inhibition and and early brain involvement in HIV infected patients. Lan.cet 1991; 33 7 : 935 - 39.
33. Connor E. Antiretroviral treatment fo children with ,human immunodeficiency virus infection Pediattics 1991; 88 : 389 - 92.
34 . William IG. Anti-HIV drugs. Medicine Intemational. 1988; 3 : 2364- 6.
35. Graham NMH, Zeger SL, Park LP, Phair JP, Detels R, Vermund SH, Ho M, Saak AJ and Multicenter AIDS cohort study. Longitudinal study in the Edinbrugh haemophilia/HlV cohort. Lancet 1991; 338: 1159- 63.
36. Blanche S, Duliege AM, Navarette MS, et al. Low dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. Pediatrics 1991; 88 : 364 - 70.
37. Kline MW, Shearer WT. A national survery on the care of infants and children with human immunodeficiency virus infection. J Pediatr 1991; 118 : 817- 21.
38. Conviser R, Grant CM, Coye M]. Pediatric acquired immunodeficiency syndrome hospitalization in new Jersey. Pediatrics 1991; 87: 642- 3.
39. Heagarty. MC. Psychological and socio consequences. World Health Nov-Dec : 18 -19.
40. Greenberg DS. Ratcheting up the AIDS hysteria. Lancet 1991; 338 : 638-4.
41. Potts M, Anderson R, Boily MC. Slowing the of human immunodeficiency virus in developing countries. Lancet 1991; 338 : 608- 12.
42. WHOb. Global Program on AIDS – Resolution WHA4234 of the Forty-second World Healthy Assembly, 1989. Geneva.
Copyright (c) 2019 Sunarto Sunarto
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Published 2019-01-30
